J&J | Kamatbevétel



Interest Income változás Dátum
AbbVie USD 92M 37M 2024-12
Abbott USD 5.26 4.32 2024-12
AstraZeneca 64M 119M 2024-12
Baxter International USD 10M 4M 2024-12
Bayer 114M 36M 2024-12
Becton, Dickinson and Co. USD 23M 32M 2024-12
Biogen USD 18.5M 6.9M 2024-12
Boston Scientific USD 4M 3M 2022-12
Dexcom 29.7M 2.3M 2024-12
Edwards Lifesciences USD 64M 64M 2024-12
Eli Lilly USD 44.3M 3.5M 2024-12
Gilead Sciences 85M 33M 2024-12
GlaxoSmithKline 32M 8M 2024-09
Globus Medical USD 815K 3.08M 2024-12
Hologic USD 24.2M 4.2M 2024-12
Indivior 5M 1000K 2024-09
Insulet USD 10.3M 200K 2024-12
Integra LifeSciences USD 4.89M 156K 2024-12
Intuitive Surgical 3.4 1.84 2024-12
J&J 292M 103M 2024-09
Medtronic USD 114M 23M 2025-01
Merck USD 146M 19M 2024-12
Merit Medical Systems USD 4.74M 1.91M 2024-12
Pfizer USD 171M 55M 2024-12
Regeneron Pharmaceuticals 8.12 3.42 2024-12
Roche Holding 2M 12M 2020-12
Sanofi 133M 41M 2024-09
Stryker USD 47M 17M 2024-12
Tandem Diabetes Care USD 4.51M 833K 2024-12
Vertex Pharmaceuticals USD 128.2M 4M 2024-12
Zoetis 1.29 0.21 2024-12



J&J Kamatbevétel - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2025.